Study: Results from Phases II/III of Clinical Trial of Gantenerumab, a Treatment for Alzheimer’s Disease
Roche has recently released the results of the latest phases of their study of gantenerumab, which is a treatment of a rare form of Alzheimer's disease. This form, which is…